Pfizer Archives -

AstraZeneca and Merck & Co’s Lynparza has been the undisputed market leader in the PARP inhibitor category for

PARP rivals close in on AZ and Merck’s market leading Lynparza

https://pharmaphorum.com/news/parp-rivals-close-in-on-az-and-mercks-market-leading-lynparza/

Boy Receiving a Vaccination During a Pandemic

Pfizer/BioNTech ask FDA for EUA of Omicron bivalent vaccine in children 5+

Nicole Raleigh BioNTech, bivalent, booster shot, Comirnaty, COVID-19, emergency use authorisation, monovalent, Omicron, paediatric, Pfizer, vaccine 0 Comment

A submission to the US Food and Drug Administration (FDA) requesting an Emergency Use Authorization (EUA) of a

Pfizer/BioNTech ask FDA for EUA of Omicron bivalent vaccine in children 5+

https://pharmaphorum.com/news/pfizer-biontech-ask-fda-for-eua-of-omicron-bivalent-vaccine-in-children/

News/ News/ R&D

Pfizer, Sangamo resume haemophilia gene therapy trial

Phil Taylor BioMarin Pharmaceuticals, gene therapy, Haematology, haemophilia, haemophilia A, Pfizer, Sangamo Therapeutics 0 Comment

Pfizer and Sangamo have restarted recruitment of patients into their registration trial for haemophilia A gene therapy giroctocogene

Pfizer, Sangamo resume haemophilia gene therapy trial

https://pharmaphorum.com/news/pfizer-sangamo-resume-haemophilia-gene-therapy-trial/

Market Access/ News/ News/ News/ Oncology

Routine NHS access to Ibrance assured with new NICE guidance

Phil Taylor breast cancer, HEOR, Ibrance, Keytruda, melanoma, Merck & Co, NHS, NICE, Oncology, Pfizer, renal cell carcinoma 0 Comment

Thousands of patients with a particular form of breast cancer in England and Wales can be confident they

Routine NHS access to Ibrance assured with new NICE guidance

https://pharmaphorum.com/news/routine-nhs-access-to-ibrance-assured-with-new-nice-guidance/

Digital/ News/ News

Data-crunching specialist CytoReason signs $110m Pfizer alliance

Phil Taylor artificial intelligence, Biomarkers, CytoReason, digital, digital health, partnering, Pfizer 0 Comment

Three years after it started working with Pfizer, artificial intelligence-powered drug discovery specialist CytoReason has converted the relationship

Data-crunching specialist CytoReason signs $110m Pfizer alliance

https://pharmaphorum.com/news/data-crunching-specialist-cytoreason-signs-110m-pfizer-alliance/

Market Access/ News/ News

CHMP says yes to Sanofi/AstraZeneca antibody for RSV prevention

Phil Taylor antibody, AstraZeneca, Beyfortus, CHMP, GlaxoSmithKline, nirsevimab, Pfizer, respiratory syncytial virus, Sanofi 0 Comment

Sanofi and AstraZeneca are closing in on EU approval of nirsevimab, their long-acting antibody for the protection of

CHMP says yes to Sanofi/AstraZeneca antibody for RSV prevention

https://pharmaphorum.com/news/chmp-says-yes-to-sanofi-astrazeneca-antibody-for-rsv-prevention/

News/ News/ R&D

Phase 3 readout sets up filings for Pfizer’s meningitis vaccine

Phil Taylor GlaxoSmithKline, meningitis, Pfizer, vaccine 0 Comment

Pfizer’s close-fought contest with GSK to bring a next-generation meningitis vaccine to market has entered the final rounds,

Phase 3 readout sets up filings for Pfizer’s meningitis vaccine

https://pharmaphorum.com/news/phase-3-readout-sets-up-filings-for-pfizers-meningitis-vaccine/

News/ News/ R&D

Pfizer, BioNTech’s mRNA flu vaccine starts phase 3 testing

Phil Taylor BioNTech, CureVac, GlaxoSmithKline, influenza, Moderna, mRNA, Pfizer, Sanofi, Translate Bio, vaccines 0 Comment

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed

Pfizer, BioNTech’s mRNA flu vaccine starts phase 3 testing

https://pharmaphorum.com/news/pfizer-biontechs-mrna-flu-vaccine-starts-phase-3-testing/

Market Access/ News/ News

Pfizer’s Omicron BA.4/BA.5 vaccine recommended by CHMP

Phil Taylor BioNTech, Comirnaty, coronavirus, COVID-19, COVID-19 vaccine, EU, Omicron, Pfizer 0 Comment

Pfizer and BioNTech’s COVID-19 vaccine targeting Omicron BA.4 and BA.5 has been recommended for authorisation by the EMA’s

Pfizer’s Omicron BA.4/BA.5 vaccine recommended by CHMP

https://pharmaphorum.com/news/pfizers-omicron-ba-4-ba-5-vaccine-recommended-by-chmp/

Trending

Pfizer

Login